Walleye Capital’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.29K Buy
+1,001
New +$3.33K ﹤0.01% 5824
2025
Q4
– Sell
-27,519
Closed -$116K – 4749
2025
Q3
$116K Sell
27,519
-5,785
-17% -$25.4K ﹤0.01% 3632
2025
Q2
$166K Sell
33,304
-102,801
-76% -$447K ﹤0.01% 3492
2025
Q1
$600K Buy
136,105
+120,812
+790% +$567K ﹤0.01% 2398
2024
Q4
$71.1K Buy
15,293
+4,259
+39% +$23.4K ﹤0.01% 4259
2024
Q3
$76.6K Sell
11,034
-19,305
-64% -$152K ﹤0.01% 4507
2024
Q2
$237K Buy
+30,339
New +$225K ﹤0.01% 4178
2024
Q1
– Sell
-12,078
Closed -$80.9K – 5558
2023
Q4
$80.9K Buy
+12,078
New +$68K ﹤0.01% 4136
2022
Q4
– Sell
-13,252
Closed -$62K – 3343
2022
Q3
$62K Sell
13,252
-422,242
-97% -$2.66M ﹤0.01% 2541
2022
Q2
$2.58M Buy
+435,494
New +$4.85M 0.07% 296
2021
Q3
– Sell
-8,900
Closed -$320K – 1674
2021
Q2
$320K Buy
+8,900
New +$328K 0.01% 907

Other funds holding GDRX

Walleye Capital's GDRX Position: Q3 2026 in Review

Walleye Capital opened a new position in GoodRx Holdings (GDRX) in Q3 2026: 1,001 shares worth $3.29K. The stake represents ﹤0.01% of the portfolio and ranks #5824 among its holdings. This is a return to the name: Walleye Capital previously reported a position in GDRX as recently as Q3 2025.

Walleye Capital first reported a position in GDRX in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.58M in Q2 2022. 181 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • Walleye Capital held 1,001 shares of GoodRx Holdings worth $3.29K as of Q3 2026.
  • GoodRx Holdings was a new Walleye Capital position in Q3 2026.
  • GoodRx Holdings made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5824 holding.
  • Walleye Capital first reported a position in GoodRx Holdings in Q2 2021 and has held it in 11 quarters since.
  • Walleye Capital's GoodRx Holdings position peaked at $2.58M in Q2 2022.
  • 181 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.